Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.32 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4095120 | 0.76 | MAOB (0.41) | KDM1A | |
| SCHEMBL4083002 | 0.69 | SLC6A4 (0.41) | SLC6A3SLC6A4SLC6A2KDM1ACYP1A2 | |
| SCHEMBL4096980 | 0.67 | ALDH1A1 (0.39) | SLC6A3SLC6A4SLC6A2MAPK1ALDH1A1 | |
| SCHEMBL15657386 | 0.67 | CFTR (0.45) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL4096847 | 0.66 | KDM1A (0.43) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL20020048 | 0.66 | TSHR (0.38) | KDM4EMEN1MAPK1KMT2AALDH1A1 | |
| SCHEMBL576944 | 0.64 | SLC6A3 (0.39) | SLC6A3SLC6A4SLC6A2KDM4EMEN1 | |
| SCHEMBL23709164 | 0.63 | MAPK1 (0.40) | SLC6A3SLC6A4SLC6A2KDM4EMEN1 | |
| SCHEMBL19809334 | 0.63 | MEN1 (0.44) | SLC6A3SLC6A4SLC6A2KDM4EMEN1 | |
| SCHEMBL1160451 | 0.63 | SLC6A3 (0.38) | SLC6A3SLC6A4SLC6A2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100512582-C | Light emitting system, light emitting method and chemical substance for light emission | HITACHI CHEMICAL CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | HOSHI YOUSUKE | 2009-06-25 | — | — | US | disclosed |
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | HITACHI CHIEMICAL CO., LTD., (JP) | 2007-06-21 | — | — | US | disclosed |
| CN-1898995-A | Light emitting system, light emitting method and chemical substance for light emission | HITACHI CHEMICAL CO LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | GLO1, TYR, GUSB | SLC6A3 243/4885SLC6A4 614/4885SLC6A2 291/4885 |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | GLO1, TYR, GUSB | SLC6A3 243/4885SLC6A4 614/4885SLC6A2 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.